These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33357645)

  • 1. Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction ≤19% on medical therapy.
    Agstam S; Bahl A; Kumar RM
    Indian Heart J; 2020; 72(6):557-562. PubMed ID: 33357645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the incidence and baseline predictors of the left ventricular ejection fraction returning to normal after dilated cardiomyopathy in postmenopausal women: a retrospective, observational study.
    Yuan X; Mao S; Tang Q
    J Int Med Res; 2020 May; 48(5):300060520922471. PubMed ID: 32429729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcome of sustained improvement in left ventricular function in dilated cardiomyopathy.
    Blechman I; Arad M; Nussbaum T; Goldenberg I; Freimark D
    Clin Cardiol; 2014 Nov; 37(11):687-92. PubMed ID: 25236761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    J Am Heart Assoc; 2021 Jun; 10(12):e019240. PubMed ID: 34053244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival of idiopathic dilated cardiomyopathy in the 1990s.
    Azuma A; Matsuo A; Nakamura T; Kawasaki T; Yamamoto K; Hyogo M; Hirata A; Hirasaki S; Shima T; Sugihara H; Kunishige H; Kuribayashi T; Nakagawa M
    Jpn Circ J; 1999 May; 63(5):333-8. PubMed ID: 10943610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin withdrawal in patients with dilated cardiomyopathy following normalization of ejection fraction with beta blockers.
    Shammas NW; Harris ML; McKinney D; Hauber WJ
    Clin Cardiol; 2001 Dec; 24(12):786-7. PubMed ID: 11768743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18-Month Outcomes of Ambulatory Patients With Reduced (≤40%) Left Ventricular Ejection Fraction Treated in a Community-Based, Dedicated Heart Failure Clinic Versus Treated Elsewhere.
    Murninkas D; Itzhaki Ben Zadok O; Iakobishvili Z; Jino H; Yohananov E; Birkenfeld S; Hasdai D
    Am J Cardiol; 2019 Apr; 123(7):1101-1108. PubMed ID: 30658921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with dilated cardiomyopathy in a contemporary Swiss population.
    Vischer A; Osswald S; Sticherling C; Schaer B
    Acta Cardiol; 2009 Jun; 64(3):347-50. PubMed ID: 19593945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin-converting enzyme inhibitor in dilated cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    ESC Heart Fail; 2022 Apr; 9(2):1175-1185. PubMed ID: 35137537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
    Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
    Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated Cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    Int Heart J; 2021 Jul; 62(4):801-810. PubMed ID: 34276005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.